Specifically, the activation of leptin signaling leads to simultaneous activation of multiple oncogenic pathways, leading to increased breast cancer cell proliferation, epithelial–mesenchymal transformation, migration, and invasion (37, 38). Here, LEP is linked to breast cancer.